Generic Drugs are less expensive yet are just as effective. The development, research, animal and human clinical trials, marketing, and advertising are not funded by the manufacturers of these medications. A non-generic drug with an expired patent may apply for a licence to market a Generic Drugs, but only if the generic drug satisfies the requirements for quality and safety as determined by the Central Drugs Standard Control Organization.
The active component in generic medications is the same one that was used in non-generic medications throughout their patent period and has undergone all clinical investigations and quality testing. As a result, these are regarded as secure. Pharmacovigilance organizations keep an eye on the effectiveness and side effects of drugs. They make certain that consumers are receiving safe and effective medications.
